EP 1192129 A2 20020403 - PHARMACEUTICAL COMPOUNDS
Title (en)
PHARMACEUTICAL COMPOUNDS
Title (de)
PHARMAZEUTISCHE VERBINDUNGEN
Title (fr)
COMPOSES PHARMACEUTIQUES
Publication
Application
Priority
- EP 0003237 W 20000411
- IT MI990750 A 19990413
Abstract (en)
[origin: WO0061549A2] Compounds or their salts of general formula (I): A-(B) wherein A = R-T1-, wherein R is the drug radical and T1 = (CO)t or (X)t', wherein X = O, S, NR1C, R1C is H or an alkyl having from 1 to 5 carbon atoms, or a free valence, t and t' are integers and equal to zero or 1, with the proviso that t = 1 when t' = 0; t = 0 when t' = 1; B = -TB-X2 wherein TB = (CO) when t = 0, TB = X when t' = -, X being as above defined; X2, monovalent radical, is such that the precursor drug of A and the precursor of B respectively meet the pharmacological tests described in the application.
IPC 1-7
C07C 327/34; C07C 69/618; C07C 69/65; C07D 207/16; C07C 211/49; C07C 219/10; C07D 209/28; C07D 233/64; C07D 277/06; C07D 277/14; C07D 295/088; C07D 309/30; C07D 401/12; C07D 407/04; C07D 417/12; C07D 473/08; C07D 495/04; C07D 499/32; C07F 9/38; C07H 15/252; A61K 31/16
IPC 8 full level
A61K 31/192 (2006.01); A61K 31/198 (2006.01); A61K 31/222 (2006.01); A61K 31/401 (2006.01); A61K 31/405 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); A61K 31/495 (2006.01); A61K 31/5415 (2006.01); A61P 39/06 (2006.01); A61P 43/00 (2006.01); C07C 69/618 (2006.01); C07C 69/65 (2006.01); C07C 219/10 (2006.01); C07C 219/24 (2006.01); C07C 327/34 (2006.01); C07C 401/00 (2006.01); C07D 207/16 (2006.01); C07D 209/18 (2006.01); C07D 233/64 (2006.01); C07D 401/12 (2006.01); C07D 241/04 (2006.01); C07D 417/12 (2006.01); C07D 495/04 (2006.01); C07D 499/32 (2006.01); C07F 9/38 (2006.01); C07H 17/07 (2006.01)
CPC (source: EP KR)
A61P 39/06 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 327/34 (2013.01 - EP KR); C07D 209/28 (2013.01 - KR); C07D 215/26 (2013.01 - KR); C07D 233/64 (2013.01 - KR); C07D 239/56 (2013.01 - KR); C07D 277/06 (2013.01 - KR); C07D 279/18 (2013.01 - KR); C07D 311/14 (2013.01 - KR); C07D 487/04 (2013.01 - KR); C07F 9/3873 (2013.01 - EP KR); C07H 17/07 (2013.01 - EP KR); C07C 2601/14 (2017.05 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0061549 A2 20001019; WO 0061549 A3 20020103; AU 3820000 A 20001114; BR 0009701 A 20020402; CA 2370406 A1 20001019; CN 1356981 A 20020703; EP 1192129 A2 20020403; HU P0200747 A2 20020629; HU P0200747 A3 20030228; IL 145632 A0 20020630; IT 1311921 B1 20020320; IT MI990750 A1 20001013; JP 2002541242 A 20021203; KR 20020005671 A 20020117; MX PA01010209 A 20030721; NO 20014926 D0 20011010; NO 20014926 L 20011213; PL 351241 A1 20030407; TR 200102939 T2 20020923
DOCDB simple family (application)
EP 0003237 W 20000411; AU 3820000 A 20000411; BR 0009701 A 20000411; CA 2370406 A 20000411; CN 00808855 A 20000411; EP 00917074 A 20000411; HU P0200747 A 20000411; IL 14563200 A 20000411; IT MI990750 A 19990413; JP 2000610825 A 20000411; KR 20017012971 A 20011011; MX PA01010209 A 20000411; NO 20014926 A 20011010; PL 35124100 A 20000411; TR 200102939 T 20000411